Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
NordX Metals Plans Private Placement to Raise Up to $2.4 Million

NordX Metals Plans Private Placement to Raise Up to $2.4 Million

BitgetBitget2026/11/03 12:32
  • NordX Metals plans to raise up to $2.4 million through a non-brokered private placement.
  • The offering comprises up to 8,000,000 units priced at $0.30 each.
  • Each unit includes one common share and one-half of one common share purchase warrant.
  • Each whole warrant entitles the holder to acquire one additional share at $0.45 for 24 months from issuance.
  • Net proceeds will fund general working capital and continued exploration of the company's properties.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nordx Metals Corp. published the original content used to generate this news brief via Newsfile (Ref. ID: 202611030730NEWSFILECNPR____20261103_322251_1) on November 03, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Dental treatment company vVardis has announced the terms for its $214 million US IPO.

智通财经•2026/11/09 06:41
"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss

Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.

智通财经•2026/11/09 06:41
Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss